Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers
- 27 February 2003
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 36 (4) , 382-392
- https://doi.org/10.1002/gcc.10138
Abstract
Chromosome region 17q12-23 commonly shows an increase in DNA copy number in breast cancers, suggesting that several oncogenes are located at this site. We performed a high-resolution expression array and comparative genomic hybridization analysis of genes mapped to the entire 17q12-23 region, to identify novel candidate oncogenes. We identified 24 genes that showed significant overexpression in breast cancers with gain of 17q12-23, compared to cancers without gain. These genes included previously identified oncogenes, together with several novel candidate oncogenes. FISH analysis using specific gene probes hybridized to tissue arrays confirmed the underlying amplification of overexpressed genes. This high-resolution analysis of the 17q12-23 region indicates that several established and novel candidate oncogenes, including a Wnt-signaling pathway member, are amplified and overexpressed within individual primary breast cancer samples. We were also able to confirm the presence of two apparently separate and reciprocally amplified groups of genes within this region. Investigation of these genes and their functional interactions will facilitate our understanding of breast oncogenesis and optimal management of this disease.Keywords
This publication has 29 references indexed in Scilit:
- Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancerBritish Journal of Cancer, 2000
- Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancersNature Genetics, 2000
- Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanismNature Genetics, 2000
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.Journal of Clinical Oncology, 1996
- Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerHuman Pathology, 1992
- Humanization of an anti-p185HER2 antibody for human cancer therapy.Proceedings of the National Academy of Sciences, 1992
- Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?European Journal Of Cancer, 1992
- Characterization of chromosomal anomalies in human breast cancerCancer Genetics and Cytogenetics, 1990
- Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancerInternational Journal of Cancer, 1988
- Cytogenetic studies on human breast carcinomasBreast Cancer Research and Treatment, 1986